The vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week.
Coronavirus vaccine update: The world recorded nearly 500,000 fresh Covid-19 cases in the last 24 hours, pushing the tally to 50,728,891. While the US caseload has crossed 10.2 million, India, France, Russia and Brazil are also struggling to curb the growth of the highly infectious virus. Every hope today is pinned on coronavirus vaccine development. Take a look at how things stand:
-There are at least 182 coronavirus vaccine candidates in pre-clinical or clinical-trial stages across the globe. Of these, nine are in final human-trial stage. In India, two vaccines are in Phase-II trials and one (the Oxford University one) in Phase-III.
-Experts have said vaccines are likely to reach the general public in the March-April 2021. Drug makers, on
First Published: Nov 06 2020 | 12:47 PM IST